Microinvasive Glaucoma

The IOP-lowering efficacy of microinvasive glaucoma surgeries has been demonstrated in a number of studies in the ophthalmic literature.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, I. Paul Singh, MD, discusses intraoperative OCT and how it is utilized within the glaucoma conventional outflow pathway space and even subconjunctival surgery.

In this Healio Video Perspective, Dave Van Meter, CEO of Ivantis, discusses the global launch of the Hydrus microstent for the treatment of glaucoma, and the data accumulated with the device over more than 4 years.

In this Healio Video Perspective, Chris Calcaterra, chief operating officer at Glaukos Corp., discusses the company’s commitment to ophthalmologists and their patients throughout the coronavirus pandemic and going forward.

KOLOA, Hawaii — At Hawaiian Eye 2020, Inder Paul Singh, MD, discusses the benefits of implementing MIGS as an early glaucoma intervention, ultimately helping surgeons reduce patient IOP, reduce number of medications needed and reduce patient chair time.

ORLANDO — At Cataract Surgery: Telling It Like It Is, Inder Paul Singh, MD, discusses the importance of introducing MIGS into practices.

MARRAKECH, Morocco — At the European Society of Cataract and Refractive Surgeons Winter Meeting, Simonetta Morselli, MD, shares her experience with the Xen gel stent (Allergan). She is one of the investigators in a European study evaluating the safety and efficacy of the new Xen 63 and explains what differentiates this option from the previous Xen 45.

ORLANDO — At Cataract Surgery: Telling It Like It Is, I. Paul Singh, MD, discusses how he has incorporated endoscopic cyclophotocoagulation in his practice in addition to MIGS procedures because ECP works to decrease inflow while most MIGS devices work to increase outflow.